BioPharma Credit (LON:BPCR) Insider Graeme Proudfoot Purchases 70,000 Shares of Company Stock

BioPharma Credit (LON:BPCR) insider Graeme Proudfoot bought 70,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 29th. The shares were purchased at an average cost of GBX 99 per share, for a total transaction of £69,300.

BioPharma Credit Stock Performance

Shares of BPCR traded down GBX 0 during mid-day trading on Wednesday, hitting GBX 0.98. 2,413,558 shares of the company’s stock were exchanged, compared to its average volume of 1,392,099. The company has a market cap of £11.00 million, a price-to-earnings ratio of 0.09 and a beta of 0.23. The stock’s 50-day moving average is GBX 0.97 and its 200-day moving average is GBX 0.96. BioPharma Credit has a fifty-two week low of GBX 0.88 and a fifty-two week high of GBX 1.

BioPharma Credit Company Profile

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.